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Background: Many factors are involved in the prognosis and outcome of Chronic
Migraine and Medication Overuse Headache (CM+MOH), and their understanding is a
topic of interest. It is well known that CM+MOHpatients experience increased psychiatric
comorbidity, such as anxiety, depression, or personality disorders. Other psychological
factors still need to be explored. The present study is aimed to evaluate whether early
life traumatic experiences, stressful life events, and alexithymia can be associated with
CM+MOH.
Methods: Three hundred and thirty-one individuals were recruited for this study. They
belonged to one of the two following groups: CM+MOH (N = 179; 79% females,
Age: 45.2 ± 9.8) and episodic migraine (EM) (N = 152; 81% females; Age: 40.7 ±
11.0). Diagnosis was operationally defined according to the International Classification
of Headache Disorders 3rd edition (ICHD-IIIβ). Data on early life (physical and emotional)
traumatic experiences, recent stressful events and alexithymia were collected by means
of the Childhood Trauma Questionnaire, the Stressful life-events Questionnaire, and the
Toronto Alexithymia Scale (TAS-20), respectively.
Results: Data showed a higher prevalence of emotional (χ²= 6.99; d.f.= 1; p= 0.006)
and physical (χ² = 6.18; d.f. = 1; p = 0.009) childhood trauma and of current stressful
events of important impact (χ² = 4.42; d.f. = 1; p = 0.025) in CM+MOH patients than
in EM ones. CM+MOH patients were characterized by higher difficulties in a specific
alexithymic trait (Factor 1 subscale of TAS-20) [F (1, 326) = 6.76, p = 0.01, ηp² = 0.02]
when compared to the EM group. The role of these factors was confirmed in amultivariate
analysis, which showed an association of CM+MOH with emotional (OR 2.655; 95% CI
1.153–6.115, p= 0.022) or physical trauma (OR 2.763; 95%CI 1.322–5.771, p= 0.007),
and a high score at the Factor 1 (OR 1.039; 95% CI 1.002–1.078, p = 0.040).
Conclusions: Our findings demonstrated a clear relationship between CM+MOH and
life traumas, stressful events, and alexithymia. These observations have a relevant role in
multiple fields of related to chronic headache: from the management to the nosographic
framing.
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Bottiroli et al. Predictors of Medication Overuse Headache
INTRODUCTION
Childhood trauma refers to psychological, physical, emotional
or sexual abuse, and emotional neglect occurring before age
17 years (Bernstein et al., 2003). Stressful life events are
instead defined as those recent events that could determine
a substantial change in one’s positive or negative personal
circumstances (Brown and Birley, 1968). Both childhood trauma
and stressful events seem to contribute in the development
of chronic pain syndromes (Lampe et al., 2003). This because
they affect nervous, immune, and endocrine systems and are
associated to the onset and perpetuation of pain later in
adulthood (Lampe et al., 2003). In this field, headache deserves
a special mention being one of the most common and disabling
disorders of the nervous system. In most sufferers, attacks
recur episodically, however a small, but significant, portion
of patients evolve into chronic migraine, often occurring in
association an excessive use of acute medications (medication
overuse headache – CM+MOH) (Olesen et al., 2006), such
as combination of analgesics, triptans, or non-steroidal anti-
inflammatory drugs (Da Silva and Lake, 2014). CM+MOH is
strongly associated with psychiatric conditions (mainly anxiety
and depression) or personality disorders (Sances et al., 2010,
2013; Bottiroli et al., 2016). Since 1990 (Merikangas et al., 1990),
the association of psychiatric disorders and headache has been
labeled as comorbidity. Defining the factors that are involved
in the association headache with psychiatric comorbidity is
compelling and helpful to overcome the cul de sac of a long-
lasting inexplicable association (Galli, 2017).
For instance, the association among early traumatic
experiences, stressful events, and the development and
perpetuation of chronic pain syndromes (Afari et al., 2014) may
be due, according to the biopsychosocial model, to a complex
interaction among biological, psychological, and psychosocial
factors reciprocally influencing each other (Andrasik et al.,
2005). We know that childhood trauma (Peterlin et al., 2007; Fuh
et al., 2010; Tietjen et al., 2010; Tietjen, 2016) and the exposure
to stressful events (D’Amico et al., 2000; Scher et al., 2003;
Schramm et al., 2015) are able to increase headache frequency,
severity, and chronicity of different headache disorders. In
particular, headache in people with childhood abuse seems to
be more disabling and frequent and more likely to transform
from episodic to chronic (Tietjen et al., 2010). Self-reported early
life traumas are, indeed, more prevalent in CM patients when
compared with those with episodic migraine (Peterlin et al.,
2007). Similarly, stressful life events are among risk factors for
the development of chronic migraine (Lipton, 2009). Moreover,
people being victim of abuse in childhood are also those being
more likely re-victimized across life span, being exposed to
increased stressful life events (Tietjen et al., 2010). However, only
a limited number of studies has explored this topic in CM+MOH
as a separate group among chronic headache sub-types. In this
field, a Turkish study (Altintas¸ et al., 2015a) failed to detect
differences in the occurrence of early life maltreatments among
CM+MOH, chronic, and episodic migraine. We recently found
that childhood trauma, together with history of depression,
are predictors of medication overuse headache (Viana et al.,
2018). As for current stressful events, a study by the Danish
group (Westergaard et al., 2016) reported a strong link between
CM+MOH and stress, even if another Turkish research failed
to identify such a relationship between medication overuse and
number of events (Altintas¸ et al., 2015b). Thus, more research is
needed in order to shed light on this argument.
Alexithymia refers to the difficulty in term of emotional
awareness, which is the ability to identify and recognize
emotions in oneself and in the others (Taylor, 2001). An
important current discussion in this field concerns whether
alexithymia could be considered as a mental state or a stable
personality trait (Taylor et al., 1997). A good position considers
that alexithymia in subjects with substance use disorders who
underwent detoxification is both a state and trait phenomenon
and does not appear to be related to changes in anxiety- and
depression-like symptoms (de Haan et al., 2014). Alexithymia is
common in chronic pain syndromes (Gulec et al., 2004; Sayar
et al., 2004), such as chronic headache associated or not with
medication overuse (Galli et al., 2017). Other fields of research
have shown the existence of an association between alexithymia
and childhood trauma (Frewen et al., 2008) and stressful life
events (Honkalampi et al., 2004). A limited number of studies
explored the occurrence of alexithymia in migraine (Balaban
et al., 2012; Kars¸ikaya et al., 2013; Galli et al., 2017).
Our hypothesis is that childhood trauma, adult stressful life
events (stressful events within the last 10 years) and alexithymia
interact with one another to influence the development of
CM+MOH. In the present study, we therefore aimed at
evaluating whether early life traumatic experiences, stressful life
events, and alexithymia are associated—on both an individual
and group level—with CM+MOH. Their presence in a subject
with migraine would therefore define a subpopulation of patients
who are at a high risk of a negative outcomes.
MATERIALS AND METHODS
Subjects
This study was conducted at the Pavia Headache Center (a
tertiary referral center) of the Mondino Foundation in Pavia,
Italy. We enrolled consecutive patients with long-term episodic
migraine (EM, history of illness >10 years who never developed
MOH) and patients with CM+MOH. The study was approved
by the Ethics Committee of San Raffaele Scientific Institute
(Milan, Italy) and written informed consent was obtained
from all patients. Recruitment started on March 2014 and was
completed in July 2016. All consecutive EM and CM+MOH
patients were enrolled. EM patients were enrolled in headache
clinics; CM+MOH patients were enrolled during the inpatient
detoxification program.
EM Patients
Inclusion criteria for patients with EM were: (a) age >18, <65
years, (b) fulfillment of ICHD-III beta criteria for migraine with
or without aura, (c) migraine duration >10 years. Exclusion
criteria were: (a) previous or present history of MOH or any
other type of chronic headache (ICHD-III beta), (b) dementia,
(c) previous diagnosis of psychosis, and (d) mental retardation.
Frontiers in Psychology | www.frontiersin.org 2 May 2018 | Volume 9 | Article 704
Bottiroli et al. Predictors of Medication Overuse Headache
Verification of the eligibility criteria was made by an expert
neurologist.
CM+MOH Patients
Inclusion criteria for patients with CM+MOH were: (a) age
>18, <65 years, (b) fulfillment of ICHD-III beta criteria for CM
and MOH. Exclusion criteria were: (a) dementia, (b) previous
diagnosis of psychosis, and (c) mental retardation. Verification
of the eligibility criteria was made by an expert neurologist.
Procedures
Each consultation was performed by a neurologist that diagnosed
the headache type, collected socio-demographic data, migraine
characteristics and history, and history of present and previous
use of medications and/or other substances. Participants also
filled a series of self-report questionnaires.
CM+MOH patients underwent a complete evaluation based
on the DSM criteria by an expert psychologist (SB or FG). EM
patients were screened for anxiety and depression using the
Hospital Anxiety and Depression Scale (Zigmond and Snaith,
1983).
For the detection and characterization of trauma, we used a
shorter Italian version (adapted by Bottiroli et al., 2017) of the
Childhood Trauma Questionnaire (Bernstein et al., 2003), which
includes 13 items referring to different types of childhood trauma
such as emotional abuse, emotional neglect, physical abuse,
physical neglect, and sexual abuse. This version of the scale, as
evaluated in the present study, has moderate internal consistency
(Cronbach’s alpha= 0.51). For each item, patients were requested
to indicate whether or not they experienced each kind of trauma.
We considered the number of participants reporting traumatic
experiences, by considering separately physical and emotional
trauma, also in terms of neglect and abuse. Stressful life-events
were assessed via the questionnaire proposed by Paykel et al.
(1971), subsequently, adapted to the Italian language by Bottiroli
et al. (2017). The questionnaires consists in a list of 58 stressful life
events (e.g., moving, divorce, newwork, dismissal, etc.), and has a
good internal consistency (Cronbach’s alpha = 0.73), as resulted
from our data. Patients were requested to tick those events that
occurred to them in the last 10 years. We considered the total
number of participants reporting stressful events. Participants
were also requested to rate the impact of each of the selected
events on their quality of life, on a 5-points Likert scale ranging
from mild to very serious. We also counted the number of
participants ticking each level of impact. A further index derived
from considering the number of participants reporting events
with at least an “important” level of impact, which derived by
summing the important, serious, and very serious impacts. In
order to understand the additional burden of having experienced
both childhood trauma and current stress, we also considered the
number of participants reporting both types of event.
The presence of alexithymia was investigated using the
20-item Italian version (Caretti et al., 2005) of the Toronto
Alexithymia Scale (TAS-20; Bagby et al., 1994), which has a
good internal consistency (Cronbach’s alpha = 0.81) as based
on literature, and contains the same three-factor structure as
the English version of the scale. Items in the first factor (Factor
1) are referred to the ability to identify feelings and distinguish
them from bodily sensations. Items in the second factor (Factor
2) relate to a concrete thinking style. Items in the third factor
(Factor 3) concern the ability to express emotion and fantasy
(daydreaming). The total scores for the TAS-20 were categorized
as follow: a score >61 indicated the presence of alexithymia,
a score of <51 indicated the absence of alexithymia; a score
between >51 and <61 indicated a borderline level (Caretti et al.,
2005).
Statistical Procedures
Data are presented asmeans± SD for continuous data and as n/%
for frequency data. The differences between EM and CM+MOH
were examined with χ² tests for categorical variables and one-
way analysis of variance (ANOVA) for quantitative variables.
Univariate and multivariate logistic regression (enter method)
were applied. The criterion for variables inclusion in univariate
model was the existence of significant differences among groups
in the ANOVAs, whereas for variables inclusion in multivariate
model was statistical significance at the level of p≤ 0.05, obtained
by univariate analysis. An alpha of 0.05 was used for all statistical
tests. All analyses were conducted using SPSS (Statistical Package
for Social Sciences, version 23.0).
RESULTS
Patient Population
Three hundred and thirty-one patients were enrolled, of which
152 suffered from EM and 179 from CM+MOH. All CM+MOH
patients enrolled had a previous multiannual history of EM.
EM Patients
Patients had the following characteristics: 81% were female
(n = 123), average age was 40.7 ± 11.0, the average age at onset
of migraine was 16.3 ± 8.7. The average monthly frequency of
migraine attacks was 6.4± 3.3.
CM+MOH Patients
Patients had the following characteristics: 79% were female
(n= 141), average age was 45.2± 9.8, the average age at onset of
migraine was 14.3 ± 8.4, the average age at onset of CM+MOH
was 23.8± 5.5.
The average frequency of headache days permonth was 26.1±
4.8, the average frequency of days ofmedication intake permonth
was 23.8 ± 5.5, and the average frequency of medication use per
month was 45.6± 34.7. No patients had abuse of opioids.
Comparison Between EM and CM+MOH
Patients
When comparing demographic and clinical features (Table 1)
between these 2 groups, we observed a older age [F(1, 319)= 15.12,
p < 0.001], lower age at onset of migraine [F(1, 317) = 4.57,
p = 0.033], and higher frequency of attacks per months
[F(1, 190) = 1073.82, p < 0.001] in CM+MOH patients when
compared to EM patients.
As regards psychological variables, as measured via self-report
questionnaires, data showed a (Table 1) significant association
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TABLE 1 | Demographic, clinical, and psychological characteristics of medication overuse headache (CM+MOH) and episodic migraine (EM) patients.
CM+MOH
N = 179
mean ± SD
EM
N = 152
mean ± SD
p
Age 45.2 ± 9.8 40.7 ± 11.0 <0.001
Gender (Female) n (%) 141 (79%) 123 (81%) 0.37
Age at onset 14.3 ± 8.4 16.3 ± 8.7 0.033
Drug doses per month 45.6 ± 34.7 – –
Days with headache per month 26.1 ± 4.8 6.4 ± 3.3 <0.001
CHILDHOOD TRAUMA QUESTIONNAIRE n (%)
Traumatic experiences (yes) 111 (62%) 73 (48%) 0.007
Emotional trauma (yes) 87 (49%) 52 (34%) 0.006
Emotional abuse (yes) 20 (11%) 11 (7%) 0.19
Emotional neglect (yes) 84 (47%) 51 (34%) 0.005
Physical trauma (yes) 65 (37%) 36 (24%) 0.009
Physical abuse (yes) 26 (15%) 12 (8%) 0.05
Physical neglect (yes) 54 (30%) 31 (20%) 0.023
STRESSFUL LIFE-EVENTS QUESTIONNAIRE n (%)
Life events (yes) 172 (96%) 132 (92%) 0.075
Mild events (yes) 67 (38%) 63 (45%) 0.13
Moderate events (yes) 104 (59%) 84 (57%) 0.49
Important events (yes) 133 (75%) 96 (68%) 0.087
Very serious events (yes) 41 (23%) 29 (20%) 0.30
Serious events (yes) 77 (43%) 52 (36%) 0.12
At least important events (yes) 151 (85%) 108 (76%) 0.025
N. of childhood trauma and stressful life events combined (%) (yes) 107 (60%) 67 (47%) 0.012
TAS-20 (TORONTO ALEXITHYMIA SCALE)
Alexithymic patients n (%) 58 (33%) 44 (29%) 0.30
Total score (20–100) 46.1 ± 11.7 44.4 ± 12.4 0.20
Factor 1 (7–35) 16.1 ± 6.7 14.3 ± 6.3 0.01
Factor 2 (5–25) 12.3 ± 4.7 12.4 ± 4.7 0.89
Factor 3 (8–40) 17.7 ± 4.6 17.7 ± 4.7 0.92
Possible range scores are indicated enclosed by brackets. Significant differences are visualized in bold.
between group and childhood trauma in CM+MOH patients
as compared to EM ones. The higher prevalence of childhood
trauma (χ² = 6.51; d.f. = 1; p = 0.007) in CM+MOH involved
both emotional (χ² = 6.99; d.f. = 1; p = 0.006) and physical
(χ² = 6.18; d.f. = 1; p = 0.009) trauma. An higher prevalence
in term of emotional neglect (χ² = 8.02; d.f. = 1; p = 0.005),
physical neglect (χ² = 5. 19; d.f. = 1; p = 0.023), and physical
abuse (χ²= 4.14; d.f.= 1; p= 0.05) was also found in CM+MOH
patients as compared to EM ones.
As for stressful life events, we found a significant association
between group and stressors of at least important impact, with
a higher prevalence of them (χ² = 4.42; d.f. = 1; p = 0.025)
in CM+MOH patients than in EM ones. No other differences
resulted across groups as concerns the stressful life-events of
minor impact (ps > 0.075).
We also detected a significant association between group and
the presence of both childhood trauma and current stressful
events, with a higher prevalence of this combination of adversities
in CM+MOHpatients (χ²= 5.64; d.f.= 1; p= 0.018) than in EM
ones.
As for TAS-20, CM+MOH patients were characterized by
higher Factor 1 scores [F(1, 326)= 6.76, p= 0.01, ηp²= 0.02] when
compared to the EM group.
No other significant differences resulted between these two
groups of patients.
Predictors of Medication Overuse
Headache
According to the results of a univariate analysis (Table 2), the
factors associated to the presence ofmedication overuse headache
were: presence of emotional (OR 1.819; 95% CI 1.165–2.838,
p = 0.022) or physical trauma (OR 1.837; 95% CI 1.134–2.976,
p = 0.013), presence of at least important current stressful life
events (OR 1.828; 95% CI 1.037–3.224, p = 0.037), presence of
both childhood trauma and stressful life events (OR 1.708; 95%
CI 1.096–2.661, p = 0.018), and a high score at the Factor 1
subscale of TAS-20 (OR 1.046; 95% CI 1.010–1.082, p = 0.010).
The presence in general of childhood trauma, as well as of
emotional and physical abuse/neglect were not introduced in
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TABLE 2 | Model fit of logistic regression equations to predict chronic migraine and medication overuse headache (CM+MOH).
Univariate OR 95% CI p-value Multivariate OR 95% CI p-value
CHILDHOOD TRAUMA QUESTIONNAIRE
Emotional trauma (yes vs. no) 1.819 1.165–2.838 0.008 2.655 1.153–6.115 0.022
Physical trauma (yes vs. no) 1.837 1.134–2.976 0.013 2.763 1.322–5.771 0.007
STRESSFUL LIFE EVENTS QUESTIONNAIRE
At least important events (yes vs. no) 1.828 1.037–3.224 0.037 – – 0.18
No. of childhood trauma and stressful life events combined (yes vs. no) 1.708 1.096–2.661 0.018 – – 0.12
TAS-20 (TORONTO ALEXITHYMIA SCALE)
Factor 1 1.046 1.010–1.082 0.010 1.039 1.002–1.078 0.04
Significant ORs are in indicated bold.
the model given that we separately considered emotional and
physical trauma.
In amultivariate analysis, the factors that emerged as predictor
of medication overuse headache were: the presence of emotional
(OR 2.655; 95% CI 1.153–6.115, p = 0.022) or physical trauma
(OR 2.763; 95% CI 1.322–5.771, p = 0.007), and a high score
at the Factor 1 subscale of TAS-20 (OR 1.039; 95% CI 1.002–
1.078, p = 0.040). This logistic regression model was statistically
significant, χ2(5) = 22.27, p < 0.001 and it explained 9.1%
(Nagelkerke R2) of the variance of medication overuse headache
and correctly classified 63.3% of cases.
DISCUSSION
The results of the present study showed that history of childhood
(emotional and physical) trauma together with stressful events
of important impact, and difficulties to identify feelings
and distinguish them from bodily sensation are substantial
determinants of CM+MOH. By contrast, CM+MOH and EM
patients are comparable in terms of stressful events of minor
impact as well as in the other alexithymic traits. Noteworthy,
the prevalence of early traumatic experiences (both physical
and emotional) in the group with EM is impressive (48%), and
higher than estimates from epidemiological studies in under
13-year old population (38%) (Koenen et al., 2010). The very
fact that the sum of childhood trauma and stressful life events
is significantly higher in CM+MOH than EM evidences a
trend toward a matched growing of headache severity and
psychological vulnerability. This is further underlined by the
marked alexithymic profile showed by CM+MOH as well.
Studies of nonclinical populations also have found that childhood
abuse predicts deficits in emotional awareness and expression
(Paivio and McCulloch, 2004). From another side, both clinical
and community studies indicated that individuals with chronic
pain were also more likely to report a history of abuse or
neglect compared to those who reported less pain symptoms or
conditions (Davis et al., 2005).
In the present study, we focused on a specific type of chronic
pain, which is complicated by medication overuse. In other
research areas, it has been shown that early life adversities
represent risk factors increasing the likelihood to develop a
variety of psychiatric disorders, including substance abuse and
dependence behaviors (Kendler et al., 2000; Dube et al., 2003;
Widom et al., 2006), due to psychological and physiological
changes induced by early and prolonged exposure to stress
(Cohen et al., 1995). The question of whether overuse of
pain-relieving drugs is the cause or the consequence of the
increased headache frequency is still a matter for debate. Previous
evidence puts CM+MOH and dependence together, suggesting
a common underlying vulnerability (Radat et al., 2008), partly
due to psychiatric comorbidity (Limmroth et al., 2002; Saper
et al., 2005). Others argued that substance abuse behaviors in
CM+MOH varied according to the types of symptomatic drugs
overused (Fuh et al., 2005; Fumal et al., 2006). By contrast,
our group (Galli et al., 2011) has previously shown that MOH
and drug addicted patients differed in those personality aspects
related to dependence and that probably CM+MOH patients
overuse medications because they need to cope with life in
spite of daily attacks of headache. A likely explanation is that
the exposure to childhood traumas causes a difficulty in these
patients to tolerate recurrent pain, making them particularly
prone to medication misuse. This point is supported by previous
evidence (Teicher and Samson, 2013) showing that individuals
having experienced childhood trauma represent “ecophenotypic
variants as clinically and neurobiologically distinct subtypes”
(p. 1114) and they differ from non-maltreated persons in
how they react to the same conditions. Given that we did
not include a group of chronic migraineurs without overuse,
our results are only speculative and need to be confirmed
by exploring how these patients respond to detoxification
treatments.
This study advances our knowledge of trauma in CM+MOH
by exploring the impact of emotional and physical events,
both resulting more prevalent in this population of patients
and resulting as significant antecedents of more complicated
expressions of migraine. What is interesting here is the
investigation of emotional trauma, which represents a less
recognized and explored type of maltreatment with respect
to physical and sexual abuse (Edwards et al., 2003). Other
studies before us have shown how emotional and physical
trauma may have consequences on migraine characteristics
(Tietjen et al., 2010; Kucukgoncu et al., 2014; Demiryürek et al.,
2017). Interestingly, we found that irrespective of the type
of trauma, any form of early life adversity may impact this
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condition, probably representing a kind of epigenetic cue with
still unknown influences on cerebral mechanisms related to pain.
It is unknown whether the influence of traumatic experience is
related specifically to migraine or to chronic pain in general, and
in this case why a traumatized patient develops migraine and no
other types of pain.
Stress is well known as one of the most common headache
trigger factors, which can increase headache frequency and
promote headache chronification (Mosley et al., 1991).
CM+MOH patients in our study were characterized by a
higher number of “at least important” stressful events than
episodic controls. It would be interesting to understand whether
CM+MOH patients are exposed to a greater number of stressful
live events or they are less able to tolerate and cope with stress
than episodic migraineurs. In literature there is limited evidence
showing a greater presence of stressors in chronic headache
patients than in healthy controls (Invernizzi et al., 1985; De
Benedictis and Lorenzetti, 1992). By contrast, stress derives
from the inability to deal with experienced life events (Nash and
Thebarge, 2006) and chronic headache patients tend to be less
able to adopt coping strategies than healthy controls (Dube et al.,
2003; Widom et al., 2006). In this frame, our findings support
the hypothesis of a greater psychological vulnerability in the
development of chronic headache associated to acute medication
overuse. Future studies should explore such findings according
to the duration of the exposure to these stressors and/or the
mediator effect of other variables (e.g., personality or cognitive
characteristics).
A specific alexithymic trait—difficulty in identifying feeling—
distinguished medication overuse headache patients from
episodic migraineurs. This result corroborates the idea that
alexithymia could represent a risk factor increasing susceptibility
to disease (Weiner, 1982). This is not particularly surprising
given that this tendency has been previously highlighted in
chronic migraineurs with medication overuse (Galli et al., 2017).
What is new here is the fact that we extended these results in the
frame of coexisting childhood traumas and life events. According
to etiological studies, alexithymia is the result of environmental
influences (Gündel et al., 2002), such as traumatization and
adversities both in childhood or adulthood. Previous studies
have shown that childhood adversities often lead to alexithymia
in adulthood, which is due to a lack of introjection of how
differentiate emotional states, regulate arousal, and respond to
challenge life events (Zlotnick et al., 2001). On the other hand,
some psychophysiological evidences showed that alexithymia
might also bias the perception of stress and lead to a decoupling
between subjective and physiological responses to it (Martin
and Pihl, 1986; Näätänen et al., 1999; Stone and Nielson, 2001).
Hence, alexithymia might lead to an inaccurate self-perception
of stressful events, which might in turn prevent an individual
from coping effectively with the stressors and, as consequence,
prolong the exposure to stress itself (Martin and Pihl, 1985).
The fact that in the present study we have found a more
evident prevalence of childhood trauma, current life events, and
alexithymic trait in CM+MOH patients with respect to episodic
migraineurs suggest the complexity of CM+MOH and that
these factors may act together and predispose the development
of this complex clinical condition. We hypothesize that early
traumatic experiences drive to the development of a kind of
psychological vulnerability which—in the case of additional
stressful events—sets the ground for chronic evolution of pain.
This does not exclude a genetic predisposition to migraine given
that these patients do not develop other types of chronic or
recurrent pain. The severity of trauma/stressful event might be
the medium toward the worst evolution of pain in the direction
of chronicity, and alexithymia an additional factor predicting
the worst outcome (CM+MOH in our case). Furthermore,
the well-known comorbidity with anxiety and mood disorders
might be related to such psychological vulnerability, predisposing
individuals to ineffective strategies of coping with adverse events.
What happens at the neurobiological level in headache patients
should be matter of further studies. To date, the pathophysiology
of migraine and its chronification is very complex and still
needs to be fully understood, being the result of structural
and functional alterations (Burstein et al., 2015). Among those
causative aspects that could determine the shift from episodic to
chronic migraine, we certainly believe that a critical role should
be attributed to psychological and psychosocial factors.
A final consideration should be paid to the fact that our two
groups of migraneurs differed only in a specific subscale of the
TAS-20, that is the one concerning difficulties in identifying
feelings and distinguishing between feelings and the bodily
sensations of emotional arousal. A recent study has shown
that alexithymic individuals could have difficulties not only in
identifying their own emotions, but also for what concerns
their non-affective interoceptive state (Brewer et al., 2016). For
instance, in other fields of research, it has been shown that
these persons could be inaccurate in perceiving their own bodily
sensations (Herbert et al., 2011) This determines a delay in
seeking medical treatment (Carta et al., 2013) and an incorrect
assumption of substances that could make them less aware of
their body (de Haan et al., 2014). The alexithymic trait in which
we found differences, among all those from the TAS-20, seems
to be the one mostly corroborating this previous finding about
non-affective interoceptive deficits, and that could explain the
medication misuse our patients had. However, future studies are
needed to further verify this hypothesis.
Our study is not free from limitations. Only CM+MOH
patients received a psychiatric evaluation based on DSM-IV
criteria (American Psychiatric Association, 1994), while EMwere
only screened for anxiety and depression using the Hospital
Anxiety and Depression Scale (Zigmond and Snaith, 1983).
We are aware that co-occurring psychiatric disorders could
complicate both headache and medication overuse behaviors.
However, we believe that, while the strong comorbid association
between depression/anxiety and chronic headache is well-known,
it is important to focus on additional psychological components,
such as child trauma and recent life events (Galli, 2017), that may
explain why some patients withmigraine evolve into CM+MOH.
We assessed childhood trauma and current stressors using
retrospective self-report questionnaires and without addressing
the duration of such exposure. However, we feel that these
findings provide an important key lecture for a phenomenon that
is largely unexplained. Furthermore, this was a cross-sectional
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study and we are not able to specify the casual trajectories
underlying the association among childhood trauma, life events,
alexithymia, and medication overuse headache. In this frame,
a potential limitation is the lower mean age detected in the
EM group as compared to the CM+MOH group, which does
not allow to exclude with absolute certainty that some of the
patients in the EM group would not evolve into CM+MOH in
the next few years. Finally, data collection procedure did not
reflect the general migraine population, given that participants
were recruited from a neurological clinic. Hence, transferability
of these findings to the general practice will require confirmation
on larger sub-groups of patients, in multi center studies, and
different cultures.
In conclusion, our results showed that childhood trauma, life
events, and alexithymia are associated to CM+MOH. From a
theoretical point of view, our data add an important element to
the identification of the risk factors for the development of this
condition. From a practical point of view, they provide useful
indications as regards the importance of optimizing patients’
management by means of a preliminary thorough evaluation
of their psychological and psychosocial history. We believe
that patients having experienced childhood traumas, important
stressful life events and presenting alexithymic traits should be
treated by clinicians also from a psychological point of view due
to high risk of negative outcome.
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